2,6-Di-tert.-butyl-3-methyl-hydrochinon | 59313-66-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,6-Di-tert.-butyl-3-methyl-hydrochinon
• 英文别名: 3,5-Ditert-butyl-2-methylbenzene-1,4-diol
• CAS: 59313-66-5
• 化学式: C₁₅H₂₄O₂
• 分子量: 236.354
• InChiKey: UWDGDMBEPBPUOR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2,6-二(叔丁基)-4-羟基-4-甲基-2,5-环己二烯-1-酮 在 potassium tert-butylate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 2,6-Di-tert.-butyl-3-methyl-hydrochinon
  参考文献：
  名称：

  Nishinaga,A. et al., Chemische Berichte, 1976, vol. 109, p. 1530 - 1548

  摘要：

  DOI：

文献信息

• Polyacetal resin composition
  申请人：POLYPLASTICS CO. LTD.

  公开号：EP0110108A2

  公开（公告）日：1984-06-13

  A polyacetal composition comprises polyacetal, an aliphatic ester of a polyhydric alcohol having a hydroxy group, polyethylene glycol and an organometallic salt.

  聚缩醛组合物由聚缩醛、具有羟基的多元醇的脂肪族酯、聚乙二醇和有机金属盐组成。
• Semiaromatic polyamide resin composition
  申请人：MITSUI CHEMICALS, INC.

  公开号：EP0864610A1

  公开（公告）日：1998-09-16

  A semiaromatic polyamide resin composition of the present invention contains a polyamide (A) in which a dicarboxylic acid component unit comprises a terephthalic acid component unit and a diamine component unit comprises a straight-chain alkylenediamine component unit and an alkylenediamine component unit having a side-chain alkyl group; and a modified ethylene/α-olefin copolymer (B) obtained by graft-modifying an ethylene/α-olefin copolymer having particular properties with an unsaturated carboxylic acid or a derivative thereof. A molded article obtained by using this composition exhibits excellent anti-creeping property under high-temperature and high-humidity conditions, and causes the metal mold to be little fouled during the molding operation.

  本发明的一种半自动聚酰胺树脂组合物含有一种聚酰胺（A），其中二羧酸组分单元包括对苯二甲酸组分单元，二胺组分单元包括直链烷基二胺组分单元和具有侧链烷基的烷基二胺组分单元；以及一种改性乙烯/α-烯烃共聚物（B），该改性乙烯/α-烯烃共聚物是通过将具有特殊性能的乙烯/α-烯烃共聚物与不饱和羧酸或其衍生物进行接枝改性而得到的。使用这种组合物制成的模塑制品在高温高湿条件下具有优异的抗蠕变性能，在模塑操作过程中几乎不会弄脏金属模具。
• REMEDIES FOR RENAL DISEASES AND ORGAN-PRESERVING AGENTS
  申请人：CHUGAI SEIYAKU KABUSHIKI KAISHA

  公开号：EP0950405A1

  公开（公告）日：1999-10-20

  Herein disclosed are therapeutic agents for renal diseases and organ preservatives containing a compound represented by the general formula (1): wherein X represents an oxygen atom or a group represented by the general formula (2): where n represents an integer from 0 to 2, R1 represents a hydrogen atom or an acyl group, R2 represents a hydrogen atom, a lower alkyl group or a lower alkenyl group, R3 represents a lower alkyl group, R4, R5 and R6, which may be the same or different, each represents a hydrogen atom or an optionally substituted alkyl group, and R6 further represents a formyl, carboxyl, lower alkoxycarbonyl or optionally substituted carbamoyl group, or R3 and R4 may be taken together to form a five-membered ring, or R5 and R6 may be taken together to form a cycloalkyl group, provided that when the five-membered ring formed by R3 and R4 and the benzene ring form benzofuran or benzo[b]thiophene, R6 is absent.

  这里公开的是含有通式（1）所代表的化合物的肾病治疗剂和器官防腐剂： 其中 X 代表氧原子或通式（2）所代表的基团： 其中 n 代表 0 至 2 的整数，R1 代表氢原子或酰基，R2 代表氢原子、低级烷基或低级烯基，R3 代表低级烷基，R4、R5 和 R6 可以相同或不同，各自代表氢原子或任选取代的烷基，R6 进一步代表甲酰基、羧基、低级烷氧基羰基或低级烷氧基羰基、羧基、低级烷氧基羰基或任选取代的氨基甲酰基，或 R3 和 R4 可结合在一起形成五元环，或 R5 和 R6 可结合在一起形成环烷基，但当 R3 和 R4 形成的五元环与苯环形成苯并呋喃或苯并[b]噻吩时，R6 不存在。
• PREVENTIVES/REMEDIES FOR ARTERIOSCLEROSIS
  申请人：CHUGAI SEIYAKU KABUSHIKI KAISHA

  公开号：EP0982029A1

  公开（公告）日：2000-03-01

  Herein disclosed are prophylactic/therapeutic agents for atherosclerosis containing a compound of general formula (1): wherein R1 represents a hydrogen atom or an acyl group, R2 represents a lower alkyl group, R3 represents a hydrogen atom or a lower alkyl group, and R4, R5 and R6 represent a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group or an aryl group, or R2 and R4 together with the oxygen atom may form a furan or dihydrofuran ring, or R5 and R6 may combine to form a cycloalkyl group or a heterosubstituted cycloalkyl group in which one or more methylene groups of the cycloalkyl group are replaced by oxygen, sulfur or alkyl-substituted nitrogen atoms, a possible optically active isomer or a pharmaceutically acceptable salt thereof, as an active ingredient.

  本发明公开了含有通式（1）化合物的动脉粥样硬化预防/治疗剂： 其中 R1 代表氢原子或酰基，R2 代表低级烷基，R3 代表氢原子或低级烷基，R4、R5 和 R6 代表氢原子、烷基、烯基、炔基或芳基，或 R2 和 R4 与氧原子一起可形成呋喃或二氢呋喃环、或 R5 和 R6 可结合形成环烷基或杂取代的环烷基，其中环烷基的一个或多个亚甲基被氧、硫或烷基取代的氮原子、可能的光学活性异构体或其药学上可接受的盐取代，作为活性成分。
• Method of producing organic EL ink and method of manufacturing organic EL device
  申请人：JOLED INC.

  公开号：US10283711B2

  公开（公告）日：2019-05-07

  A method of producing an organic electroluminescent ink includes reducing ozone contained in an organic electroluminescent mixture comprising an organic electroluminescent material and a solvent.

  生产有机电致发光墨水的方法包括还原有机电致发光混合物中所含的臭氧，该混合物由有机电致发光材料和溶剂组成。